What is ZTS's current stock price?

As of now, ZTS is trading at $146.59, with a daily change of +0.12%.

What are the risks associated with ZTS stock?

ZTS Key risk is its Low Risk Level, .

What is ZTS next earnings date?

ZTS next earnings report is scheduled for Nov 4, 2025.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ZTS Stock Analysis & IQ Rating | Zoetis

ZTS

Zoetis

$146.59

+$0.17 | +0.12%

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 184.41

MKT CAP

$ 64.92B

52W Low

$ 139.34

VOL

$ 526.24K

P/E Ratio

25.22

AVG VOL

$ 2.99M

RSI

54.51

TREND

Sideways

ZTS Stock IQ

Login to see Zoetis (ZTS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ZTS Target Price

Login to display

Strengths

ZTS Rewards

Earnings are forecast to grow

ZTS Rewards

Pays a reliable dividend

Risk Analysis

ZTS Risk Analysis

Trading above its fair value

Chart

$143.49 (+2.16%)

$147.91 (-0.89%)

$170.3 (-13.92%)

$170.37 (-13.96%)

1year

6month

3month

1month

ZTS Risk Level

ZTS has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

LOW

HIGH

ZTS Analysts Opinion

ZTS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

ZTS Analysts Opinion

ZTS Analysts opinion is positive but there was a setback from the past 3 months

ZTS Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

80%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

0%

100%

ZTS Street Opinion

ZTS Street view is extremely bullish and have positive views on the near-term outlook

ZTS Performance Sentiment

Sentiments overview associated with ZTS events and the stock performance.

80%

7%

Positive

Negative

12 out of 15
events present

1 out of 15
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$145.84

Resistance
Price

$141.11

Current Price Range

$148.34

Show methods +

ZTS Earnings

The TTM reflects 12-month period, providing review of ZTS financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

9,385

9,256

8,544

+4.81%

Cost of Revenue

2,679

2,719

2,561

+2.28%

Gross Profit

6,706

6,537

5,983

+5.87%

Operating Exp

3,186

3,145

2,914

+4.56%

Operating Inc

3,520

3,392

3,069

+7.10%

Net Interest Inc

-123

-119

-134

-

Interest Exp

215

225

239

-5.15%

Interest Inc

92

106

105

-6.39%

Other Inc Exp

-79

-140

1

-

EPS Growth

5.81

5.47

5.08

+6.94%

ZTS Financial Health

The company financial health has moderately improved over the past year

Financial Score

3.64

Next Earnings Date: Nov 4, 2025

Linked to ZTS

IQ

Close Price

Change

MRK

4.05

87.69

+0.56%

ZTS Latest Analysis +

UBS Maintains Zoetis (ZTS) Neutral Recommendation. Fintel reports that on October 20 2025 UBS maintained coverage of Zoetis (NYSE:ZTS) with a Neutral recommendation. Analyst Price Forecast Suggests 34.73% Upside

Tue Oct 21, 2025

$146.09 | +0.66%

Potential

Rating

Zoetis Stock: Outlook Remains Muted. Zoetis Inc. (NYSE:ZTS) is currently in its final 18th phase of the Adhishthana cycle on the weekly charts. Having formed a poor triad structure the stock'.s outlook doesn'.t look encouraging. With UBS recently lowering its price targets it adds further weight to the view that Zoetis could stay stuck in a slump through June 2026. In the Adhishthana framework the behavior of Phase 18 is largely determined by Phases 14 15 and 16 collectively known as the

Tue Oct 21, 2025

$146.09 | +0.66%

Activity

Momentum

Valideas Top Health Care Stocks Based On Martin Zweig - 10/20/2025. The following are the top rated Health Care stocks according to Valideas Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth reasonable valuations and low debt.ZOETIS

Mon Oct 20, 2025

$145.06 | +0.69%

Activity

Valideas Top Health Care Stocks Based On Martin Zweig - 10/15/2025. The following are the top rated Health Care stocks according to Valideas Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth reasonable valuations and low debt.ZOETIS

Wed Oct 15, 2025

$142.12 | -0.93%

Activity

Zoetis Gets Health Canada Approval For Lenivia To Treat Osteoarthritis Pain In Dogs . (RTTNews) - Zoetis Inc. (ZTS) on Wednesday announced that Health Canada has approved Lenivia for the alleviation of pain associated with osteoarthritis (OA) in dogs.

Wed Oct 15, 2025

$142.12 | -0.93%

Activity

Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again. Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Tue Oct 14, 2025

$143.46 | +0.84%

Earnings

Potential

Zoetis Gains CVMP Backing for Lenivia Eyes EU Approval in Dog OA Pain . ZTS secures CVMPs positive opinion recommending the approval of Lenivia a long-acting OA pain therapy for dogs with the final decision expected in late 2025.

Mon Oct 13, 2025

$142.26 | +0.81%

Activity

Potential

Zoetis gains EMA panel endorsement for Lenivia for osteoarthritis pain in dogs.

Fri Oct 10, 2025

$141.11 | -1.50%

Activity

Zoetis declares $0.50 dividend.

Thu Oct 9, 2025

$143.39 | -0.07%

Activity

Why Zoetis (ZTS) Remains a Reliable Choice for Investors Seeking Profitable Dividend Stocks. Zoetis Inc. (NYSE:ZTS) is included among the 13 Most Profitable Dividend Stocks to Buy Right Now. Zoetis Inc. (NYSE:ZTS) offers a range of drugs and healthcare products for companion animals and livestock worldwide. The company keeps innovating with a portfolio that includes seven main product categories and about 300 product lines. As younger generations show [….]

Wed Oct 8, 2025

$143.49 | +0.50%

Potential

FAQ About ZTS Stock Insights

What is ZTS current stock price?

What are ZTS stock strengths?

What risks are associated with ZTS stock?

When is ZTS next earnings report?

What is ZTS market cap and volume?

What is ZTS's current Stock IQ?

Should I buy ZTS stock right now?

Is ZTS a Strong Buy right now?

What does a 'Strong Buy' rating mean for ZTS?

What does a 'Strong Sell' rating mean for ZTS?

What factors influence ZTS's Stock IQ?

Explore our ZTS Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ZTS Stock Strategies
Effective Risk Management

FIND US ON

Receive our ZTS Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ZTS

Zoetis

Current Price

$146.59

+$0.17 | +0.12%

52W High

$ 184.41

MKT CAP

$ 64.92B

52W Low

$ 139.34

VOL

$ 526.24K

P/E Ratio

25.22

AVG VOL

$ 2.99M

RSI

54.51

TREND

Sideways

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

ZTS Rewards

Earnings are forecast to grow

ZTS Rewards

Pays a reliable dividend

Risk Analysis

ZTS Risk Analysis

Trading above its fair value

Linked to ZTS

Symbol

IQ

Close

Change

MRK

4.05

87.69

+0.56%

ZTS Stock IQ

Login to unlock Zoetis (ZTS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$143.49 (+2.16%)

$147.91 (-0.89%)

$170.3 (-13.92%)

$170.37 (-13.96%)

1year

6month

3month

1month

ZTS Analysts Opinion

ZTS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

ZTS Analysts Opinion

ZTS Analysts opinion is positive but there was a setback from the past 3 months

ZTS Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

80%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

0%

100%

ZTS Street Opinion

ZTS Street view is extremely bullish and have positive views on the near-term outlook

ZTS Risk Level

ZTS has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

LOW

HIGH

ZTS Performance Sentiment

Sentiments overview associated with ZTS events and the stock performance.

80%

7%

Positive

Negative

12 out of 15
events present

1 out of 15
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$145.84

Resistance
Price

$141.11

Current Price Range

$148.34

Show methods +

ZTS Earnings

The TTM data reflects the most recent 12-month period, providing overview of ZTS financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

9,385

9,256

8,544

+4.81%

Cost of Revenue

2,679

2,719

2,561

+2.28%

Gross Profit

6,706

6,537

5,983

+5.87%

Operating Exp

3,186

3,145

2,914

+4.56%

Operating Inc

3,520

3,392

3,069

+7.10%

Net Interest Inc

-123

-119

-134

-

Interest Exp

215

225

239

-5.15%

Interest Inc

92

106

105

-6.39%

Other Inc Exp

-79

-140

1

-

EPS Growth

5.81

5.47

5.08

+6.94%

ZTS Financial Health

The company financial health has moderately improved over the past year

Financial Score

3.64

Next Earnings Date: Nov 4, 2025

ZTS Latest Analysis

UBS Maintains Zoetis (ZTS) Neutral Recommendation. Fintel reports that on October 20 2025 UBS maintained coverage of Zoetis (NYSE:ZTS) with a Neutral recommendation. Analyst Price Forecast Suggests 34.73% Upside

Tue Oct 21, 2025

$146.09 | +0.66%

Potential

Rating

Zoetis Stock: Outlook Remains Muted. Zoetis Inc. (NYSE:ZTS) is currently in its final 18th phase of the Adhishthana cycle on the weekly charts. Having formed a poor triad structure the stock'.s outlook doesn'.t look encouraging. With UBS recently lowering its price targets it adds further weight to the view that Zoetis could stay stuck in a slump through June 2026. In the Adhishthana framework the behavior of Phase 18 is largely determined by Phases 14 15 and 16 collectively known as the

Tue Oct 21, 2025

$146.09 | +0.66%

Activity

Momentum

Valideas Top Health Care Stocks Based On Martin Zweig - 10/20/2025. The following are the top rated Health Care stocks according to Valideas Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth reasonable valuations and low debt.ZOETIS

Mon Oct 20, 2025

$145.06 | +0.69%

Activity

Valideas Top Health Care Stocks Based On Martin Zweig - 10/15/2025. The following are the top rated Health Care stocks according to Valideas Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth reasonable valuations and low debt.ZOETIS

Wed Oct 15, 2025

$142.12 | -0.93%

Activity

Zoetis Gets Health Canada Approval For Lenivia To Treat Osteoarthritis Pain In Dogs . (RTTNews) - Zoetis Inc. (ZTS) on Wednesday announced that Health Canada has approved Lenivia for the alleviation of pain associated with osteoarthritis (OA) in dogs.

Wed Oct 15, 2025

$142.12 | -0.93%

Activity

Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again. Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Tue Oct 14, 2025

$143.46 | +0.84%

Earnings

Potential

Zoetis Gains CVMP Backing for Lenivia Eyes EU Approval in Dog OA Pain . ZTS secures CVMPs positive opinion recommending the approval of Lenivia a long-acting OA pain therapy for dogs with the final decision expected in late 2025.

Mon Oct 13, 2025

$142.26 | +0.81%

Activity

Potential

Zoetis gains EMA panel endorsement for Lenivia for osteoarthritis pain in dogs.

Fri Oct 10, 2025

$141.11 | -1.50%

Activity

Zoetis declares $0.50 dividend.

Thu Oct 9, 2025

$143.39 | -0.07%

Activity

Why Zoetis (ZTS) Remains a Reliable Choice for Investors Seeking Profitable Dividend Stocks. Zoetis Inc. (NYSE:ZTS) is included among the 13 Most Profitable Dividend Stocks to Buy Right Now. Zoetis Inc. (NYSE:ZTS) offers a range of drugs and healthcare products for companion animals and livestock worldwide. The company keeps innovating with a portfolio that includes seven main product categories and about 300 product lines. As younger generations show [….]

Wed Oct 8, 2025

$143.49 | +0.50%

Potential

Discover ZTS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ZTS. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ZTS Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ZTS Stock trends

ZTS Stock performance

ZTS Stock analysis

ZTS investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ZTS

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ZTS

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

ZTS Stock Analysis & IQ Rating | Zoetis

ZTS Stock IQ

ZTS Target Price

ZTS Risk Level

ZTS Analysts Opinion

ZTS Street Consensus

ZTS Performance Sentiment

Technical Price Levels

ZTS Financial Health

Explore our ZTS Stock insights

Receive our ZTS Daily Alerts

ZTS Stock IQ

ZTS Street Consensus

ZTS Risk Level

Technical Price Levels

Discover ZTS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ZTS. We're here to help you make informed investment decisions today.

Receive our ZTS Daily Alerts

ZTS Runner Alarm